Isolyser (OREX)- Any comments Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Isolyser (OREX)- Any comments

OREX 0.223

-34.4%

Apr 3 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sandy who wrote (496)	7/10/1997 11:42:00 AM
From: W. Kent Ward	of 617

Sandy, if Isolyser's sales of its other products are increasingly greater than its cost of sales and operating expenses and therefore sufficient to drive earnings per share (EPS) growth, OREX stock value should justify itself and grow similarly. Obviously, that is the fundamental and primary objective that management must achieve to grow shareholder value. In my opinion, EPS needs to become positive at a sufficient growth rate to reach an annual "run rate" of at least $.15 to $.20 in next 12 months to justify today's value on a fundamental basis (i.e. a PE of ~20-25). If EPS growth perception is higher, momentum players will drive the PE multiple higher and thus the market value per share. If the latter happens, we will see spikes similar to the last few days, but based on more tangible news that this recent PR implies. On the other hand, if EPS languishes and no EPS growth is perceived in a reasonable timeframe, stock price will go down from today's levels. Lots of contingencies... hope this is of help.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next